Scratching the Surface of BTK Inhibition for Chronic Spontaneous Urticaria: Beyond Skin Deep
BTK inhibitors have demonstrated great promise for addressing various treatment challenges for chronic urticaria patients by improving symptom control and more effective targeting of disease pathways.
Category
  • LivDerm
  • TME
Format
  • Monograph
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
Cost $0.00
JAK is Out of the Box: Leveling Up Care for Severe Alopecia Areata Across Patient Populations
Severe alopecia areata (AA) causes a significant disease burden impacting multiple aspects of patients’ health, quality of life, and daily functioning.
Category
  • LivDerm
  • TME
Format
  • Monograph
Credits
  • 0.75 AAPA Category I CME
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC
  • 0.75 Participation
Cost $0.00
Trading Steroids for Targeted Topical Therapies: Clinical Pearls for Your AD, Psoriasis, and Seborrheic Dermatitis Patients
While corticosteroids hold a valuable place in the therapeutic toolkit for atopic dermatitis, psoriasis, seborrheic dermatitis, and similar conditions, targeted topical therapies may offer better options for individualized care.
Category
  • LivDerm
  • TME
Format
  • Monograph
Credits
  • 0.50 AAPA Category I CME
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC
  • 0.50 Participation
Cost $0.00